These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 34492272)

  • 1. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
    Tzeng HT; Chyuan IT; Lai JH
    Biochem Pharmacol; 2021 Nov; 193():114760. PubMed ID: 34492272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The JAK/STAT signaling pathway: from bench to clinic.
    Hu X; Li J; Fu M; Zhao X; Wang W
    Signal Transduct Target Ther; 2021 Nov; 6(1):402. PubMed ID: 34824210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.
    Banerjee S; Biehl A; Gadina M; Hasni S; Schwartz DM
    Drugs; 2017 Apr; 77(5):521-546. PubMed ID: 28255960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.
    Xue C; Yao Q; Gu X; Shi Q; Yuan X; Chu Q; Bao Z; Lu J; Li L
    Signal Transduct Target Ther; 2023 May; 8(1):204. PubMed ID: 37208335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases.
    Hosseini A; Gharibi T; Marofi F; Javadian M; Babaloo Z; Baradaran B
    J Cell Physiol; 2020 Sep; 235(9):5903-5924. PubMed ID: 32072644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance.
    Sabaawy HE; Ryan BM; Khiabanian H; Pine SR
    Carcinogenesis; 2021 Dec; 42(12):1411-1419. PubMed ID: 34415330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms.
    Liu J; Wang F; Luo F
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK/STAT disruption induces immuno-deficiency: Rationale for the development of JAK inhibitors as immunosuppressive drugs.
    Cornez I; Yajnanarayana SP; Wolf AM; Wolf D
    Mol Cell Endocrinol; 2017 Aug; 451():88-96. PubMed ID: 28131742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organogenesis and tumorigenesis: insight from the JAK/STAT pathway in the Drosophila eye.
    Wang YH; Huang ML
    Dev Dyn; 2010 Oct; 239(10):2522-33. PubMed ID: 20737505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease.
    O'Shea JJ; Plenge R
    Immunity; 2012 Apr; 36(4):542-50. PubMed ID: 22520847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunoevasive strategy through clinically-relevant pan-cancer genomic and transcriptomic alterations of JAK-STAT signaling components.
    Chang WH; Lai AG
    Mol Med; 2019 Nov; 25(1):46. PubMed ID: 31684858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The regulation of JAKs in cytokine signaling and its breakdown in disease.
    Hammarén HM; Virtanen AT; Raivola J; Silvennoinen O
    Cytokine; 2019 Jun; 118():48-63. PubMed ID: 29685781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mining for JAK-STAT mutations in cancer.
    Constantinescu SN; Girardot M; Pecquet C
    Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus.
    Valle-Mendiola A; Gutiérrez-Hoya A; Soto-Cruz I
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The JAK-STAT pathway: impact on human disease and therapeutic intervention.
    O'Shea JJ; Schwartz DM; Villarino AV; Gadina M; McInnes IB; Laurence A
    Annu Rev Med; 2015; 66():311-28. PubMed ID: 25587654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.
    Zhao R; Hu Z; Zhang X; Huang S; Yu G; Wu Z; Yu W; Lu J; Ruan B
    Cell Commun Signal; 2024 Jan; 22(1):68. PubMed ID: 38273295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK-STAT signaling in cancer: From cytokines to non-coding genome.
    Pencik J; Pham HT; Schmoellerl J; Javaheri T; Schlederer M; Culig Z; Merkel O; Moriggl R; Grebien F; Kenner L
    Cytokine; 2016 Nov; 87():26-36. PubMed ID: 27349799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer].
    Yang X; Tang Z; Zhang P; Zhang L
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):45-51. PubMed ID: 30674393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
    Liu Y; Holdbrooks AT; De Sarno P; Rowse AL; Yanagisawa LL; McFarland BC; Harrington LE; Raman C; Sabbaj S; Benveniste EN; Qin H
    J Immunol; 2014 Jan; 192(1):59-72. PubMed ID: 24323580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The JAK/STAT signaling cascade in gastric carcinoma (Review).
    Khanna P; Chua PJ; Bay BH; Baeg GH
    Int J Oncol; 2015 Nov; 47(5):1617-26. PubMed ID: 26398764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.